Cited by 916Sepsis Diagnosis and TreatmentHemodynamic Monitoring and TherapyTrauma, Hemostasis, Coagulopathy, Resuscitation

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Angiotensin II for the Treatment of Vasodilatory Shock

Open access

Khanna, Ashish, English, Shane W., Wang, Xueyuan S., Ham, Kealy, Tumlin, James, Szerlip, Harold, Busse, Laurence W., Altaweel, Laith, Albertson, Timothy E., Mackey, Caleb, McCurdy, Michael T., Boldt, David W., Chock, Stefan, Young, Paul J., Krell, Kenneth, Wunderink, Richard G., Ostermann, Marlies, Murugan, Raghavan, Gong, Michelle N., Panwar, Rakshit, Hästbacka, Johanna, Favory, Raphael, Venkatesh, Balasubramanian, Thompson, B. Taylor, Bellomo, Rinaldo, Jensen, Jeffrey, Kroll, Stew, Chawla, Lakhmir S., Tidmarsh, George F., Deane, Adam M.·2017·New England Journal of Medicine

DOI 10.1056/nejmoa1704154

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Vasodilatory shock that does not respond to high-dose vasopressors is associated with high mortality. We investigated the effectiveness of angiotensin II for the treatment of patients with this condition. METHODS: We randomly assigned patients with vasodilatory shock who were receiving more than 0.2 μg of norepinephrine per kilogram of body weight per minute or the equivalent dose of another vasopressor to receive infusions of either angiotensin II or placebo. The primary end point was a response with respect to mean arterial pressure at hour 3 after the start of infusion, with response defined as an increase from baseline of at least 10 mm Hg or an increase to at least 75 mm Hg, without an increase in the dose of background vasopressors. RESULTS: A total of 344 patients were assigned to one of the two regimens; 321 received a study intervention (163 received angiotensin II, and 158 received placebo) and were included in the analysis. The primary end point was reached by more patients in the angiotensin II group (114 of 163 patients, 69.9%) than in the placebo group (37 of 158 patients, 23.4%) (odds ratio, 7.95; 95% confidence interval [CI], 4.76 to 13.3; P<0.001). At 48 hours, the mean improvement in the cardiovascular Sequential Organ Failure Assessment (SOFA) score (scores range from 0 to 4, with higher scores indicating more severe dysfunction) was greater in the angiotensin II group than in the placebo group (-1.75 vs. -1.28, P=0.01). Serious adverse events were reported in 60.7% of the patients in the angiotensin II group and in 67.1% in the placebo group. Death by day 28 occurred in 75 of 163 patients (46%) in the angiotensin II group and in 85 of 158 patients (54%) in the placebo group (hazard ratio, 0.78; 95% CI, 0.57 to 1.07; P=0.12). CONCLUSIONS: Angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors. (Funded by La Jolla Pharmaceutical Company; ATHOS-3 ClinicalTrials.gov number, NCT02338843 .).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1704154

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

APACHE II
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine (see contributors to the project in the appendix)
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907118 · Cited by 1,940
Epidemiology of severe sepsis
Mayr, F., Yende, S. P., & Angus, D. C. (2013) · Virulence · doi:10.4161/viru.27372 · Cited by 1,298
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock*
López, A., Lorente, J. A., Steingrub, J. S., Bakker, J., McLuckie, A., Willatts, S. M., Brockway, M., Anzueto, A., Holzapfel, L., Breen, D. P., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000105581.01815.c6 · Cited by 917
Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock
Morelli, A., Ertmer, C., Westphal, M., Rehberg, S. W., Kampmeier, T., Ligges, S., Orecchioni, A., D’Egidio, A., D''Ippoliti, F., Raffone, C., et al. (2013) · JAMA · doi:10.1001/jama.2013.278477 · Cited by 739
History about the discovery of the renin-angiotensin system.
Basso, N., & Terragno, N. (2001) · HYPERTENSION · doi:10.1161/hy1201.101214 · Cited by 236
Survival After Shock Requiring High-Dose Vasopressor Therapy
Brown, S. M., Lanspa, M. J., Jones, J. P., Kuttler, K. G., Li, Y., Carlson, R., Miller, R. R., Hirshberg, E. L., Grissom, C. K., & Morris, A. H. (2013) · CHEST Journal · doi:10.1378/chest.12-1106 · Cited by 211

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 2

Chawla LS, 2017, Crit Care Resusc, 19, 43
Bassi E, 2013, Crit Care Res Pract, 2013, 654708

Sorted by citations

Items 401–500 of 916

The effects of vasopressor choice on renal outcomes in septic shock: a systematic review of randomised trials as a guide for future research
McDonald, R., Burns, M., Wong, A., Smith, C. E., Ostermann, M., & Hutchings, S. (2025) · Critical Care · doi:10.1186/s13054-025-05573-7 · Cited by 9
Self-citation
Evaluation of Evidence, Pharmacology, and Interplay of Fluid Resuscitation and Vasoactive Therapy in Sepsis and Septic Shock
Barlow, B., & Bissell, B. D. (2021) · Shock · doi:10.1097/shk.0000000000001783 · Cited by 9
Manejo clínico del shock poscardiotomía en pacientes adultos
Vela, J. L. P., Jorge, C. L., Duerto, J., & Rivera, J. J. J. (2021) · Medicina Intensiva · doi:10.1016/j.medin.2021.08.007 · Cited by 9
Use of sildenafil in patients with severe COVID-19 pneumonitis
McFadyen, C., Garfield, B., Mâncio, J., Ridge, C. A., Semple, T. R., Keeling, A., Ledot, S., Patel, B. V., Samaranayake, C. B., McCabe, C., et al. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.04.004 · Cited by 9
Advances in Sepsis Care
Jackson, K. E., & Semler, M. W. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.05.003 · Cited by 11
Recent trends in septic shock management: a narrative review of current evidence and recommendations
Nofal, M. A., Shitawi, J., Altarawneh, H. B., Alrosan, S., Alqaisi, Y., Al-Harazneh, A.-M., Alamaren, A. M., & Abu‐Jeyyab, M. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002048 · Cited by 10
Assessment of frequency and reporting of design changes among clinical drug trials published in influential medical journals
Shepshelovich, D., Yahav, D., Tibau, A., & Amir, E. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.08.009 · Cited by 10
Cardiogenic Shock in Perioperative and Intraoperative Settings: A Team Approach
Masud, F. N., Gheewala, G., Giesecke, M., Suarez, E. E., & Ratnani, I. (2020) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-16-1-e1 · Cited by 9
Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis
Hasegawa, D., Lee, Y. I., Prasitlumkum, N., Chopra, L., Nishida, K., Smith, R. L., & Sato, R. (2022) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2022.10.006 · Cited by 9
CE: A Review of the Revised Sepsis Care Bundles
Lester, D., Hartjes, T. M., & Bennett, A. (2018) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000544139.63510.b5 · Cited by 9
Major publications in the critical care pharmacotherapy literature: January–December 2017
Hammond, D. A., Baumgartner, L. J., Cooper, C. M., Donahey, E. E., Harris, S. A., Mercer, J. M., Morris, M., Patel, M. K., Plewa-Rusiecki, A. M., Poore, A., et al. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.02.012 · Cited by 9
Another Role for Angiotensin II?: Vasopressin-Refractory Shock After Pheochromocytoma Resection: A Case Report
Hylton, D. J., Minot, P. R., & Mihm, F. G. (2019) · A&A Practice · doi:10.1213/xaa.0000000000001144 · Cited by 9
Modern Vasopressor Therapy of Septic Shock (Review)
Kochkin, А. А., Yavorovskiy, A. G., Бондоевич, Б. Л., & Likhvantsev, V. V. (2020) · General Reanimatology · doi:10.15360/1813-9779-2020-2-77-93 · Cited by 9
Angiotensin II Administration in Patients With COVID-19 Shock
Ofosu-Barko, K., Liu, Y., Tamimi, F. A., Al-Husami, W., Ganatra, S., Resnic, F. S., & Shah, S. P. (2020) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000246 · Cited by 9
Use of Hydroxycobolamin in the Prevention of Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass: A Controlled Prospective Trial
Salah, D., Ahmed, S., & Ibrahim, D. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.02.001 · Cited by 8
ADJUNCTIVE VASOPRESSORS AND SHORT-TERM MORTALITY IN ADULTS WITH SEPTIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS
Bauer, S. R., Wieruszewski, P. M., Bissell, B. D., Dugar, S. P., Sacha, G. L., Sato, R., Siuba, M., Schleicher, M. C., Vachharajani, V., Falck-Ytter, Y. T., et al. (2025) · Shock · doi:10.1097/shk.0000000000002558 · Cited by 8
Early multimodal vasopressor strategy in septic shock (TRICYCLE)—Study protocol for a randomized controlled clinical trial
Kalamar, Ž., Gorenjak, M., Landoni, G., & Markota, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331304 · Cited by 8
Management of Sepsis in Hospitalized Patients
Palakshappa, J. A., & Taylor, S. P. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-02685 · Cited by 8
Blood pressure response index trajectories identify distinct hemodynamic phenotypes and predict mortality in septic shock: a two-database retrospective cohort study
Shen, Y., Zhang, W. M., Lin, K., Zheng, P., Liu, X., Weng, J., & Ye, Y. (2026) · Critical Care · doi:10.1186/s13054-026-06059-w · Cited by 8
Vasopressor Therapy and the Brain: Dark Side of the Moon
Heming, N., Mazeraud, A., Azabou, É., Moine, P., & Annane, D. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2019.00317 · Cited by 9
Renin-Angiotensin-Aldosterone System
Speth, R. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00160-2 · Cited by 8
Outcomes Following the Use of Angiotensin II in Patients with Postoperative Vasoplegic Syndrome
Konkol, S., Morrisette, M., Hulse, M. C., Enfield, K. B., & Mihalek, A. D. (2022) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_98_21 · Cited by 8
How We Would Treat Our Own Lung Transplantation: A Multidisciplinary and International Perspective
Martin, A. K., Reed, A. K., Höetzenecker, K., & Fessler, J. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.07.042 · Cited by 8
Intraoperative Versus Postoperative Hydroxocobalamin for Vasoplegic Shock in Cardiothoracic Surgery
Khandekar, D., Seelhammer, T. G., Mara, K. C., Stephens, E. H., Wittwer, E. D., & Wieruszewski, P. M. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.08.145 · Cited by 8
Current therapeutic strategies for acute kidney injury
Negi, S., Wada, T., Matsumoto, N., Muratsu, J., & Shigematsu, T. (2023) · Renal Replacement Therapy · doi:10.1186/s41100-023-00502-2 · Cited by 8
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock
Mergoum, A. M., Rhone, A., Larson, N. J., Dries, D. J., Blondeau, B., & Rogers, F. B. (2024) · Journal of Intensive Care Medicine · doi:10.1177/08850666241246230 · Cited by 8
Development and validation of a nomogram to predict the risk of vancomycin-related acute kidney injury in critical care patients
Bao, P., Sun, Y., Qiu, P., & Li, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1389140 · Cited by 10
Management of Sepsis in the First 24 Hours: Bundles of Care and Individualized Approach
Coloretti, I., Tosi, M., Biagioni, E., Busani, S., & Girardis, M. (2024) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0044-1789185 · Cited by 8
Exploratory Studies on RNAi-Based Therapies Targeting Angiotensinogen in Hypertension: Scoping Review
Menezes, A. D. S., Nogueira, T. H. M., de Lima, K. B. A., de Oliveira, H. L., & Botelho, S. M. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm15010003 · Cited by 8
Synthetic Human Angiotensin II in Pediatric Patients With Vasodilatory Shock: A Report on Two Patients
Bailey, D. M., Chima, R. S., Tidmarsh, G. F., & Williams, M. D. (2019) · Critical Care Explorations · doi:10.1097/cce.0000000000000036 · Cited by 8
Self-citation
Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock
Allen, J. M., & Gilbert, B. W. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.09.014 · Cited by 8
Effective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report
Bobeck, K. A., Holtzclaw, A. W., Brown, T. E., & Clark, P. A. (2020) · A&A Practice · doi:10.1213/xaa.0000000000001221 · Cited by 8
Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience
Heinicke, U., Adam, E., Sonntagbauer, M., von Knethen, A., Zacharowski, K. D., & Neb, H. (2020) · Critical Care · doi:10.1186/s13054-020-03143-7 · Cited by 8
Comparison of shock reversal with high or low dose hydrocortisone in intensive care unit patients with septic shock: A retrospective cohort study
Bonnin, S. S., Radosevich, J. J., Lee, Y. G., Feldman, J. P., & Barletta, J. F. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.12.001 · Cited by 8
Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis
Durst, M. M., Eitzen, E. A., & Benken, S. T. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020980727 · Cited by 8
Feasibility and safety of angiotensin II administration in general ward patients during COVID-19 pandemic: a case series
Morselli, F., Vitali, G., Brioschi, E., Terlizzi, G. D., Belletti, A., Lombardi, G., Senarighi, G., Neto, A. S., Zangrillo, A., & Landoni, G. (2020) · Critical Care and Resuscitation · doi:10.51893/2020.4.rl1 · Cited by 8
Dose equivalence between metaraminol and norepinephrine in critical care
Sardaneh, A. A., Goradia, S., Narayan, S. W., Penm, J. H.-D., McLachlan, A. J., & Patanwala, A. E. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14969 · Cited by 8
Standard care versus individualized blood pressure targets among critically ill patients with shock: A multicenter feasibility and preliminary efficacy study
Panwar, R., van Haren, F. M. P., Cazzola, F. E., Nourse, M., Brinkerhoff, G., & Quail, A. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154052 · Cited by 8
Self-citation
ACE2 Promoted by STAT3 Activation Has a Protective Role in Early-Stage Acute Kidney Injury of Murine Sepsis
Chen, T., Fang, Z., Zhu, J., Lv, Y., Li, D., & Pan, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.890782 · Cited by 9
Inotropes and Vasopressors Use in Critical Care and Perioperative Medicine: Evidence-Based Approach (Review)
Belletti, A., Azzolini, M. L., Baldetti, L., Landoni, G., Franco, A., & Zangrillo, A. (2022) · General Reanimatology · doi:10.15360/1813-9779-2022-5-60-77 · Cited by 8
Perioperative Management of Patients with Sepsis and Septic Shock, Part I
Bughrara, N. F., Cha, S., Safa, R., & Pustavoitau, A. (2020) · Anesthesiology Clinics · doi:10.1016/j.anclin.2019.10.013 · Cited by 8
Catecholamine-Sparing Effect of Angiotensin II in an Anephric Patient With Mixed Shock After Cardiac Revascularization Surgery: A Case Report
Cutler, N. S., & Khanna, A. K. (2020) · A&A Practice · doi:10.1213/xaa.0000000000001266 · Cited by 8
Self-citation
Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-art and expert consensus
Carsetti, A., Bignami, E., Cortegiani, A., Donadello, K., Donati, A., Foti, G., Grasselli, G., ROMAGNOLI, S., Antonelli, M. M., Blasio, E. D., et al. (2021) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.14866-1 · Cited by 8
Angiotensin II in vasodilatory shock: lights and shadows
Antonucci, E., Agosta, S., & Sakr, Y. L. (2017) · Critical Care · doi:10.1186/s13054-017-1869-9 · Cited by 8
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial
Monti, G., Konkayev, A. K., Carta, S., Bradić, N., Bruni, A., Kotani, Y., Guarracino, F., Redkin, I. V., Biondi‐Zoccai, G., Benedetto, U., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107319 · Cited by 7
Self-citation
Can Use of Intravenous Methylene Blue Improve the Hemodynamics and Outcome of the Patients with Refractory Septic Shock? An Observational Study
Rajbanshi, L. K., Arjyal, B., Bajracharya, A., & Devkota, D. (2023) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24535 · Cited by 7
Pharmacological management of sepsis in adults with a focus on the current gold standard treatments and promising adjunctive strategies: evidence from the last five years
Kyriazopoulou, E., & Giamarellos‐Bourboulis, E. J. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1589451 · Cited by 7
B-type natriuretic peptide is upregulated by c-Jun N-terminal kinase and contributes to septic hypotension
Hoffman, M., Kyriazis, I. D., Dimitriou, A., Mishra, S. K., Koch, W. J., & Drosatos, K. (2020) · JCI Insight · doi:10.1172/jci.insight.133675 · Cited by 7
Challenges and importance of formulae equating catecholamine and non-catecholamine vasoconstrictor dosages
Wieruszewski, P. M., & Khanna, A. K. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.12.020 · Cited by 7
Self-citation
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients
Zangrillo, A., Colombo, S., Scandroglio, A. M., Fominskiy, E. V., Pieri, M., Calabró, M. G., Beccaria, P. F., Pasculli, N., Guzzo, F., Calvi, M. R., et al. (2021) · Critical Care and Resuscitation · doi:10.51893/2021.2.oa9 · Cited by 7
Self-citation
Hemodilution in high‐risk cardiac surgery: Laboratory values, physiological parameters, and outcomes
Mladinov, D., Padilla, L. A., Leahy, B., Norman, J. B., Enslin, J., Camp, R. S., Eudailey, K. W., Tanaka, K. A., & Davies, J. E. (2022) · Transfusion · doi:10.1111/trf.16844 · Cited by 7
All intraoperative hypotension is not created equal – A call for an individualized approach
Khanna, A. K., Zarbock, A., & Legrand, M. M. (2023) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2023.111076 · Cited by 7
Self-citation
Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series
Tezel, O., Hutson, T. K., Gist, K. M., Chima, R. S., Goldstein, S. L., & Stanski, N. L. (2023) · Critical Care Explorations · doi:10.1097/cce.0000000000000978 · Cited by 7
Sepsis Management in the Cardiac Intensive Care Unit
Zhang, Y., McCurdy, M. T., & Ludmir, J. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10100429 · Cited by 8
Self-citation
Efficacy and Safety of Perioperative Angiotensin II Versus Phenylephrine as a First‐Line Continuous Infusion Vasopressor in Kidney Transplant Recipients
Beltran, L. P., Benken, J. J., Jou, J., Benedetti, E., Nishioka, H., Alamreia, E., Belcher, R. M., & Benken, S. T. (2024) · Clinical Transplantation · doi:10.1111/ctr.15432 · Cited by 7
Evolution of a Burn Care Network
Mullins, F., & Lineaweaver, W. C. (2018) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000001375 · Cited by 7
Timing of administration of epinephrine predicts the responsiveness to epinephrine in norepinephrine-refractory septic shock: a retrospective study
Kasugai, D., Nishikimi, M., Nishida, K., Higashi, M., Yamamoto, T., Numaguchi, A., Takahashi, K., Matsui, S., & Matsuda, N. (2019) · Journal of Intensive Care · doi:10.1186/s40560-019-0377-1 · Cited by 7
Vasopressor-Refractory Shock From Clozapine Overdose Treated With Synthetic Angiotensin II Infusion
Wieruszewski, P. M., Nelson, S. Y., Wittwer, E. D., & Leung, J. G. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000185 · Cited by 7
Pre-treatment with the angiotensin receptor 1 blocker losartan protects renal blood flow and oxygen delivery after propofol-induced hypotension in pigs
Franzén, S., & Frithiof, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-74640-6 · Cited by 7
Clinical Effect of Systemic Steroids in Patients with Cirrhosis and Septic Shock
Serafim, L. P., Simonetto, D. A., Anderson, A. L., Choi, D. H., Weister, T. J., Hanson, A. C., Kamath, P. S., Gajic, O., & de Moraes, A. G. (2021) · Shock · doi:10.1097/shk.0000000000001822 · Cited by 7
Renoprotective Roles of Curcumin
Yaribeygi, H., Maleki, M., Majeed, M. A., Jamialahmadi, T., & Sahebkar, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73234-9_38 · Cited by 7
Human atrial natriuretic peptide for acute kidney injury in adult critically ill patients: A multicenter prospective observational study
Fujii, T., Sato, T. S., Uchino, S., Doi, K., Iwami, T., & Kawamura, T. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.11.032 · Cited by 7
Atrial arrhythmia related outcomes in critically ill COVID‐19 patients
Colon, C. M., Barrios, J. G., Chiles, J. W., Brown, T. M., Pogwizd, S. M., McElwee, S., Gandotra, S., Russell, D. W., McElderry, H. T., & Maddox, W. R. (2021) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14221 · Cited by 7
Circulating biomarkers to assess cardiovascular function in critically ill
van Lier, D. P. T., & Pickkers, P. (2021) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000829 · Cited by 7
Angiotensin II and Vasoplegia in Cardiac Surgery: Paradigm Changer or Costly Contender?
Chow, J. H., Strauss, E. R., & Mazzeffi, M. A. (2020) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2020.08.060 · Cited by 7
Renin Kinetics and Mortality—Same, Same But Different?*
Khanna, A. K. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005157 · Cited by 7
Self-citation
The Renin–Angiotensin–Aldosterone System in Cardiac Surgery and Angiotensin II Therapy for Vasoplegia
Zarbock, A., Vincent, J., Backer, D. D., Bellomo, R., Legrand, M. M., Khanna, A. K., Ostermann, M., Kotfis, K., Filippo, A., Wieruszewski, P. M., et al. (2025) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007779 · Cited by 6
Self-citation
Updates in the Management of Perioperative Vasoplegic Syndrome
Brennan, K. M., Bhutiani, M., Kingeter, M. A., & McEvoy, M. D. (2022) · Advances in Anesthesia · doi:10.1016/j.aan.2022.07.010 · Cited by 7
Impact of Continuous Renal Replacement Therapy Initiation on Urine Output and Fluid Balance: A Multicenter Study
White, K. C., Laupland, K. B., See, E. J., Neto, A. S., & Bellomo, R. (2023) · Blood Purification · doi:10.1159/000530146 · Cited by 7
Self-citation
Patterns of inflammatory immune responses in patients with septic shock receiving vitamin C, hydrocortisone, and thiamine: clustering analysis in Korea
You, S., Kweon, O. J., Jung, S., Baek, M. S., & Kim, W. (2023) · Acute and Critical Care · doi:10.4266/acc.2023.00507 · Cited by 6
V asopressin I nitiation as a S econd-Line Vaso P ressor in Early S eptic S hock (VISPSS)
Ragoonanan, D., Nickelsen, P. M., Tran, N., Allen, B., Emborski, R., Legare, A., Vilella, A. L., Hampson, L., Busey, K. V., Shomo, E., et al. (2023) · Journal of Intensive Care Medicine · doi:10.1177/08850666231201364 · Cited by 6
Angiotensin-II for vasoplegia following cardiac surgery
Johnson, A. J., Tidwell, W. P., McRae, A. S., Henson, C. P., & Hernández, A. (2023) · Perfusion · doi:10.1177/02676591231215920 · Cited by 6
CRITICAL NOREPINEPHRINE DOSE TO PREDICT EARLY MORTALITY DURING CIRCULATORY SHOCK IN INTENSIVE CARE: A RETROSPECTIVE STUDY IN 3423 ICU PATIENTS OVER 4-YEAR PERIOD
Ceausu, D., Boulet, N., Roger, C., Alonso, S., Lefrant, J., Boisson, C., Mura, T., & Muller, L. (2024) · Shock · doi:10.1097/shk.0000000000002454 · Cited by 6
Angiotensin II—Real-Life Use and Literature Review
Petrun, A. M., & Markota, A. (2024) · Medicina · doi:10.3390/medicina60091483 · Cited by 6
Genetic variants associated with sepsis-associated acute kidney injury
Douville, N. J., Bastarache, L. A., Bertucci, E. M., Patil, S. B., Jewell, E. S., Freundlich, R. E., Kertai, M. D., & Engoren, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311318 · Cited by 6
A Case Report of Angiotensin II Use in the Treatment of Refractory Shock due to Amlodipine and Lisinopril Toxicity
Keller, J. H., Kendric, K. J., & LeSaint, K. T. (2024) · Case Reports in Critical Care · doi:10.1155/crcc/7543758 · Cited by 6
Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery
Miles, T. J., Guinn, M. T., Suero, O. R., Rosengart, T. K., Moon, M. R., Coselli, J. S., Ghanta, R. K., & Chatterjee, S. (2025) · JTCVS Open · doi:10.1016/j.xjon.2025.04.014 · Cited by 6
Hydroxocobalamin for vasoplegia in cardiac surgery: a retrospective cohort analysis
Zakaria, L., Shah, K. S., Yang, D., Kelava, M., Elgharably, H., Khanna, A. K., Ahuja, S., Hohlfelder, B., Alfirevic, A., Duncan, A. E., et al. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.05.026 · Cited by 6
Self-citation
Dexmedetomidine versus propofol or midazolam in patients with abdominal sepsis regarding inflammatory response and capillary leak
Moeen, S. M., El-Hakeem, E. E. A., Abdalla, E. M., Embaby, I., Hassan, H. M., & Ismail, E. A. (2021) · Egyptian Journal of Anaesthesia · doi:10.1080/11101849.2021.2006468 · Cited by 6
Estrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva · doi:10.1016/j.medin.2022.02.003 · Cited by 6
Association of Methylene Blue Dosing With Hemodynamic Response for the Treatment of Vasoplegia
Hohlfelder, B., Douglas, A., Wang, L., Wanek, M. R., & Bauer, S. R. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.04.003 · Cited by 6
Selepressin in Septic Shock
Antonucci, E., Giovini, M., Agosta, S., Sakr, Y. L., & Léone, M. (2022) · Shock · doi:10.1097/shk.0000000000001932 · Cited by 6
Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients
Andrews, L. J., Benken, J. J., Benedetti, E., Nishioka, H., Pierce, D. R., Dalton, K., Han, J. S., Shin, B., & Benken, S. T. (2022) · Clinical Transplantation · doi:10.1111/ctr.14754 · Cited by 6
Systemic thrombolytic and ultrasound-assisted catheter-directed thrombolysis for treatment of acute pulmonary embolism: a 7-year, multicenter experience
Kuebel, D., Winter, J., Martin, L., Bernardoni, B., Federle, L., Dykes, N. H., Fleet, S. L. V., Weaver, M., & Bennett, S. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02760-z · Cited by 6
Dexmedetomidine only regimen for long-term sedation is associated with reduced vasopressor requirements in septic shock patients: A retrospective cohort study from MIMIC-IV database
Li, L., Shi, X., Xiong, M., Kong, K., Chen, Z., Zhou, S., Zeng, Z., An, S., & Xu, B. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1107251 · Cited by 6
The renin–angiotensin–aldosterone system update: full-court press
PROVENZANO, A. M., & Sparks, M. A. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz123 · Cited by 6
COVID-19 and haemodynamic failure: a point of view on mechanisms and treatment
Jasiński, T., & Stefaniak, J. J. (2020) · Anaesthesiology Intensive Therapy · doi:10.5114/ait.2020.101813 · Cited by 6
Vasopressin for persistent hypotension due to amlodipine and olmesartan overdose: A case report
Matsushime, S., & Kuriyama, A. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102292 · Cited by 6
Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients
Krishnan, K., Wassermann, T. B., Tednes, P., Bonderski, V. A., & Rech, M. A. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.11.003 · Cited by 7
Renin signals renal hypoperfusion during Parkland fluid resuscitation of severe burns - a prospective longitudinal cohort study.
Vieweg, R., Järemo, M., Steinvall, I., Elmasry, M., Abdelrahman, I., & Sjöberg, F. (2020) · PubMed Central · Cited by 6
Fifty Years of Management of Vasodilatory Shock
Arias, J., Lévy, B., & Backer, D. D. (2019) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000226 · Cited by 6
Adjunctive vasopressors in distributive shock: How soon is early?
Garcia, B., & Legrand, M. M. (2023) · Critical Care · doi:10.1186/s13054-023-04500-y · Cited by 6
Impact of Continuous Renal Replacement Therapy on Outcomes in Septic Shock Patients Receiving Polymyxin B Hemoperfusion: A Retrospective Cohort Study
Chang, W.-H., Yang, S.-H., Shen, H.-F., Hu, T.-Y., & Wu, W.-J. (2025) · Biomedicines · doi:10.3390/biomedicines13122904 · Cited by 5
Ultra-early versus early adjunctive vasopressin initiation after norepinephrine escalation in septic shock: a target trial emulation
Nakashima, T., Ichinomiya, T., Nakajima, M., Shinozaki, T., Shibata, J., Goto, T., Sato, S., & Hara, T. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08575-3 · Cited by 5
Clinical approach to vasoplegia in the transplant patient from the Pediatric Heart Transplant Society
Deshpande, S. R., Bearl, D. W., Eghtesady, P., Henderson, H., Auerbach, S. R., Jeewa, A., Bansal, N., Amdani, S. M., Richmond, M. E., Sacks, L. D., et al. (2022) · Pediatric Transplantation · doi:10.1111/petr.14392 · Cited by 5
Angiotensin II as a Vasopressor for Perioperative Hypotension in Solid Organ Transplant
Benken, S. T., Thomas, R., Fraidenburg, D. R., & Benken, J. J. (2024) · Biomedicines · doi:10.3390/biomedicines12081817 · Cited by 5
The polymyxin‐B direct hemoperfusion OPTimal Initiation timing with Catecholamine PMX ‐ OPTIC study: A multicenter retrospective observational study
Nakamura, K., Okazaki, T., Tampo, A., Mochizuki, K., Kanda, N., Ono, T., Yanagita, K., Shimomura, T., Murase, T., Saito, K., et al. (2024) · Artificial Organs · doi:10.1111/aor.14865 · Cited by 5
Improvements in Vasopressor Requirements With Venovenous Extracorporeal Membrane Oxygenation
Odish, M. F., Pollema, T. L., Ignatyev, A., Lipinski, J., Yi, C., Parrett, M., Tong, K., Liu, L., Malhotra, A., & Owens, R. L. (2024) · CHEST Critical Care · doi:10.1016/j.chstcc.2024.100111 · Cited by 5
Evaluation of Angiotensin II in Patients With Catecholamine-Resistant Vasodilatory Shock Requiring Continuous Renal Replacement Therapy (ANGEL CRRT)
Rettele, M., Mohamed, A., Berry, T. P., Wilson, S. S., Welge, J. A., Shemanski, S. S., Shriver, R. L., Jallu, S. S., Haines, M. M., Douglas, A. J., et al. (2025) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2025.01.042 · Cited by 5
Clinical and Genetic Factors Associated with Intraoperative Minimum Alveolar Concentration Ratio: A Single-center Retrospective Cohort and Genome-wide Association Study
Douville, N. J., Jewell, E. S., Zhao, X., Colquhoun, D. A., Bertucci, E. M., Zöllner, S. K., Davis, R. P., Kumar, S. S., & Mashour, G. A. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005602 · Cited by 5

Authors: Khanna, A., English, S. W., Wang, X. S., Ham, K., Tumlin, J., Szerlip, H., Busse, L. W., Altaweel, L., Albertson, T. E., Mackey, C., McCurdy, M. T., Boldt, D. W., Chock, S., Young, P. J., Krell, K., Wunderink, R. G., Ostermann, M., Murugan, R., Gong, M. N., Panwar, R., Hästbacka, J., Favory, R., Venkatesh, B., Thompson, B. T., Bellomo, R., Jensen, J., Kroll, S., Chawla, L. S., Tidmarsh, G. F., & Deane, A. M.
Affiliations: Cleveland Clinic (US)
Regions Hospital (US)
Inova Health System (US)
Albert Einstein College of Medicine (US)
University of Maryland, Baltimore (US)
Northwestern University (US)
ORCID: Khanna, Ashish
English, Shane W.
Ham, Kealy
Szerlip, Harold
Busse, Laurence W.
Albertson, Timothy E.
McCurdy, Michael T.
Young, Paul J.
Wunderink, Richard G.
Ostermann, Marlies
Murugan, Raghavan
Gong, Michelle N.
Panwar, Rakshit
Hästbacka, Johanna
Venkatesh, Balasubramanian
Thompson, B. Taylor
Bellomo, Rinaldo
Chawla, Lakhmir S.
Deane, Adam M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2017-08-03
Volume: 377
Issue: 5
Pages: 419-430
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1704154
OpenAlex: W2614578436
Cited by: 916
References: 24
Citations by year: 2026: 100 · 2025: 103 · 2024: 121 · 2023: 103 · 2022: 90 · 2021: 95 · 2020: 123 · 2019: 80 · 2018: 75 · 2017: 25
FWCI: 64.87
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (submittedVersion)
Figshare (submittedVersion)
Työväentutkimus Vuosikirja (submittedVersion)
Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
NOVA (University of Newcastle Australia) (submittedVersion)
Funders: Bristol-Myers Squibb
GlaxoSmithKline
La Jolla Pharmaceutical Company
Alexion Pharmaceuticals
Regeneron Pharmaceuticals
Genentech
Topics: Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
Keywords: angiotensin II, vasodilatory shock, septic shock, vasopressors, norepinephrine, mean arterial pressure, SOFA score, mortality, blood pressure response, adverse events, sepsis treatment, vasopressor-refractory shock, fluid resuscitation, vasopressor dose reduction, organ dysfunction, 28-day mortality
MeSH terms: Aged, Angiotensin II, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypotension, Male, Middle Aged, Shock, Vasoconstrictor Agents, Organ Dysfunction Scores

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin II for the Treatment of Vasodilatory Shock

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks